Study to evaluate optimized retreatment and prolonged therapy with bortezomib

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-004795-11

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The objective of this study is to describe the effect of optimized retreatment with bortezomib in combination with dexamethasone followed by prolonged therapy with bortezomib, versus standard retreatment with bortezomib in combination with dexamethasone on PFS.


Critère d'inclusion

  • Multiple myeloma